Confusions around medical weight loss cost and insurance coverage often deter individuals from pursuing treatment
Peptides are often administered through subcutaneous injections, though other forms like oral tablets or nasal sprays also exist, offering flexibility in treatment
However, post-market data from patient reports and smaller observational studies have documented mood-related side effects in a subset of users, suggesting that certain individuals may be more vulnerable than others
In this installment, were highlighting three recalls for compounded semaglutide and tirzepatide and one recall for the GLP-1 brand-name drug Wegovy (tirzepatide)
However, in August 2017, GSK announced that it intended to withdraw the drug from the worldwide market by July 2018 for economic reasons
The publication of the Harvard study in July 2024 may trigger constructive knowledge in some states, potentially starting the limitations clock for patients who had already experienced vision loss